Login / Signup

Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: Final results of a multicenter phase II study.

Naoya KatoMasatoshi KudoKaoru TsuchiyaAtsushi HagiharaKazushi NumataHiroshi AikataYoshitaka InabaShunsuke KondoKenta MotomuraNaohiro OkanoMasafumi IkedaManabu MorimotoShingo KurodaAkiko Kimura
Published in: Hepatology research : the official journal of the Japan Society of Hepatology (2023)
Cabozantinib showed efficacy and a manageable safety profile in Japanese patients with advanced HCC.
Keyphrases
  • phase ii study
  • open label
  • locally advanced
  • metastatic renal cell carcinoma
  • squamous cell carcinoma
  • cross sectional
  • randomized controlled trial
  • rectal cancer
  • radiation therapy
  • clinical trial
  • study protocol